EUDA Health (NASDAQ:EUDA) & Inspire Medical Systems (NYSE:INSP) Head to Head Contrast

Inspire Medical Systems (NYSE:INSPGet Free Report) and EUDA Health (NASDAQ:EUDAGet Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.

Earnings & Valuation

This table compares Inspire Medical Systems and EUDA Health”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inspire Medical Systems $802.80 million 3.54 $53.51 million $1.47 66.46
EUDA Health $4.01 million 12.82 -$15.36 million ($0.12) -11.33

Inspire Medical Systems has higher revenue and earnings than EUDA Health. EUDA Health is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 2.3% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Inspire Medical Systems and EUDA Health, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems 1 7 11 0 2.53
EUDA Health 1 0 0 0 1.00

Inspire Medical Systems currently has a consensus price target of $138.88, indicating a potential upside of 42.15%. Given Inspire Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than EUDA Health.

Risk and Volatility

Inspire Medical Systems has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.16, indicating that its stock price is 116% less volatile than the S&P 500.

Profitability

This table compares Inspire Medical Systems and EUDA Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Inspire Medical Systems 5.05% 9.41% 7.97%
EUDA Health N/A N/A N/A

Summary

Inspire Medical Systems beats EUDA Health on 13 of the 14 factors compared between the two stocks.

About Inspire Medical Systems

(Get Free Report)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.